Isao Okazaki

Dr. Isao Okazaki


Research Focus & Metrics

Academic Career Length

60Years (1967-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Gut
Verified
Journal Article
Closed access
PDF file
YIY Inagaki
Y Inagaki
IOIsao Okazaki
Isao Okazaki
TGFβ is a member of a large family of pleiotropic cytokines that includes bone morphogenetic proteins (BMPs), activins and other related factors. Mammals have three different forms of TGFβ (β1, β2 and β3). Although the three isoforms of TGFβ are encoded by distinct genes located on different chromosomes, they have approximately 80% homology at the level of amino acid sequence. Of these, TGFβ1 has been most extensively studied for its roles in various pathophysiological conditions.

22 December 2006 in Hepatology
Verified
Journal Article
Open access
PDF file
RHReiichi Higashiyama
Reiichi Higashiyama
YIYutaka Inagaki
Yutaka Inagaki
YHYun Yu Hong
Yun Yu Hong
MKMiwa Kushida
Miwa Kushida
SNSachie Nakao
Sachie Nakao
IOIsao Okazaki
Isao Okazaki
Liver fibrosis is usually progressive, but it can occasionally be reversible if the causative agents are adequately removed or if patients are treated effectively. However, molecular mechanisms responsible for this reversibility of liver fibrosis have been poorly understood. To reveal the contribution of bone marrow (BM)-derived cells to the spontaneous regression of liver fibrosis, mice were treated with repeated carbon tetrachloride injections after hematopoietic reconstitution with enhanced green fluorescent protein (EGFP)-expressing BM cells. The distribution and characteristics of EGFP-positive (EGFP+) cells present in fibrotic liver tissue were examined at different time points after cessation of carbon tetrachloride intoxication. A large number of EGFP+ cells were observed in liver tissue at peak fibrosis, which decreased during the recovery from liver fibrosis. Some of them, as well as EGFP-negative (EGFP−) liver resident cells, expressed matrix metalloproteinase (MMP)-13 and MMP-9. Whereas MMP-13 was transiently expressed mainly in the cells clustering in the periportal areas, MMP-9 expression and enzymatic activity were detected over the resolution process in several different kinds of cells located in the portal areas and along the fibrous septa. Therapeutic recruitment of BM cells by granulocyte colony-stimulating factor (G-CSF) treatment significantly enhanced migration of BM-derived cells into fibrotic liver and accelerated the regression of liver fibrosis. Experiments using transgenic mice overexpressing hepatocyte growth factor (HGF) indicated that G-CSF and HGF synergistically increased MMP-9 expression along the fibrous septa. Conclusion: Autologous BM cells contribute to the spontaneous regression of liver fibrosis, and their therapeutic derivation could be a new treatment strategy for intractable liver fibrosis. (Hepatology; 2007:213–222.)

1 November 1974 in Nature
Verified
Journal Article
Closed access
IOIsao Okazaki
Isao Okazaki
KMKatsuya Maruyama
Katsuya Maruyama

1 October 2009 in Gastroenterology
Verified
Journal Article
Closed access
RHReiichi Higashiyama
Reiichi Higashiyama
TMTadashi Moro
Tadashi Moro
SNSachie Nakao
Sachie Nakao
KMKenichiro Mikami
Kenichiro Mikami
HFHiroshi Fukumitsu
Hiroshi Fukumitsu
YIYutaka Inagaki
Yutaka Inagaki

1 August 2000 in Journal of Hepatology
Verified
Journal Article
Closed access
TWTetsu Watanabe
Tetsu Watanabe
MNMaki Niioka
Maki Niioka
SHShigenari Hozawa
Shigenari Hozawa
KKKaori Kameyama
Kaori Kameyama
THTatsuhiko Hayashi
Tatsuhiko Hayashi
IOIsao Okazaki
Isao Okazaki

1 April 1982 in Life Sciences
Verified
Journal Article
Closed access
KMKatsuya Maruyama
Katsuya Maruyama
LFLawrence Feinman
Lawrence Feinman
ZFZev Fainsilber
Zev Fainsilber
MNMasayuki Nakano
Masayuki Nakano
IOIsao Okazaki
Isao Okazaki
CLCharles S. Lieber
Charles S. Lieber